A new, unique and unrivalled Rat/Mouse PINP assay for Pharmaceutical, Clinical and Academic Research Organizations.
IDS is pleased to announce that their new, unique immunoassay, Rat/Mouse PINP is now available.
The IDS Rat/Mouse PINP is the first commercial EIA to allow the specific assessment of type I collagen levels in rodent specimens*. The use of this assay will aid the assessment of new osteoporosis drug candidates in pre-clinical studies and is therefore ideal for Pharmaceutical, Clinical and Academic Research Organizations alike.
The IDS Rat/Mouse P1NP EIA is very flexible and measures P1NP released from collagen synthesis in rats or mice (plasma or serum). The cross-reactivity with human-derived P1NP is not detectable.
The assay is very simple to perform and results are available in under 3 hours. The assay format and quality also allows one operator to perform over 160 tests per day ensuring high sample throughput and precise, sensitive results.
The combination of 8 well microtiter strips and up to 12 months shelf life also makes this kit ideal for academic researchers with low sample throughput providing quicker and more cost-effective results.
The IDS PINP EIA further expands the range what we believe to be the largest range of Bone & Cartilage Immunoassays available globally.
CONTACT : Dean Hutchinson
HEAD OF MARKETING, IDS LTD
TELEPHONE : +44 (0) 191) 519 6104
FAX : +44 (0) 191) 519 0760
E-MAIL : deanh@idsltd.com
* Additional Information
The generation of type I collagen is a crucial step in bone formation where type I collagen is the major organic component of bone matrix. Propeptides are cleaved from both the N- and C-terminal ends of the procollagen molecule in equimolar concentrations during collagen synthesis(1). Thus, the quantification of N-terminal propeptide of type I procollagen (PINP) provides measurement of collagen synthesis and/or bone formation. |